NEWS
Jun 04, 2025

A Statement Regarding Peptide Sourcing

The SSRP is a medical education institute. We do not sell peptides. Our platform serves as a global scientific forum which promotes peptide science alongside cellular medicine education and clinical applications. It enables open dialogue and innovation through its support of the highest ethical and legal standards.

Our mission is to “improve patient outcomes, together”. This includes informing you how to protect both your patients and your license. Please take the time to discern the differences in peptide sourcing. This information is crucial for the safety of your patients, and the legal risks to you and your practice.

RUO Peptides

Some companies solicit research-use-only (RUO) peptides that exist outside human drug approval and/or prescription requirements. These products are for laboratory, educational, and investigational purposes only, not clinical, therapeutic, or diagnostic applications. They are labeled “not for human use” or “for research use only” as a legal disclaimer in an attempt to remove liability from the manufacturer in the context of human administration. Clinically prescribing or administering RUO peptides — even if they are third-party tested — violates federal and state board of pharmacy laws. The FDA sees this as misbranding and distribution of unapproved new drugs, and it’s legally indefensible in a court of law. Providers can get sued, have their license suspended, and face jail time for offering RUO meds directly from their clinics.

What If They Claim They’re Not RUO?

Even when a vendor claims their peptides are “pharma-grade” or “direct from manufacturer,” unless they are a licensed pharmacy, they are not legally authorized to sell medications for human use — and neither 3rd-party testing nor disclaimers remove this liability.

Compounded Peptides

If you have specific questions about how to source peptides appropriately, please reach out to your preferred compounding pharmacy. If you do not have one, we have several listed publicly on our website. Compounding pharmacies exist inside of a highly regulated, prescription drug supply chain. If you cannot find a particular peptide within their formulary, ask about substitutes they offer. If they do not ship to your state, ask your local compounding pharmacist how you can support them in their efforts to continue providing legitimate custom peptides for patients.

In Summary

Online injectable peptides that are not received from a legitimate compounding pharmacy are illegal. Period. Clinics can get raided, and providers can get shut down, if they are found to be prescribing them and storing them with intent to use clinically.

Compounding pharmacies compound drugs for human use for individually identified patients pursuant to a medical provider’s prescription. They ship directly to the patient, and patients’ rights to peptide therapy are protected under federal patient personal use laws.

Please consult with your legal counsel to ensure that, if you’re going to provide appropriate clinical guidance on peptide therapy, you’re doing so in a way that protects your patient’s health and your ability to continue to better ensure their safety.

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
SSRP Institute Mar 11, 2026
SSRP Institute Announces Troscriptions as New Trusted Partner 
WILLOUGHBY, Ohio, [Mar 11, 2026] — The SSRP Institute today announced the addition of Troscriptions as its newest Trusted Partner, following nomination by SSRP Fellow Dr. Elizabeth Yurth and upon completion of the organization’s internal clinical review and vetting process. Troscriptions offers physician-formulated, pharmaceutical grade, precision-dosed health optimization formulations delivered through a buccal troche. This […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Mar 9, 2026
Ep. 078 - The Effects of AG1® Supplementation on the Gut Microbiome of Healthy Adults
Preview Only
Journal Club – Episode 078

The Effects of AG1® Supplementation on the Gut Microbiome of Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Dr. Seeds reviews a randomized controlled study on AG1 and its potential impact on the gut microbiome. The research shows short-term probiotic survival and safety but no significant changes in microbiome diversity or systemic metabolic effects. Dr. Seeds discusses what the study supports, what it doesn’t, and why careful interpretation of research matters in clinical practice. (Article Link)

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
Feb 26, 2026
The Role of Spermidine and Endothelial Regeneration
William Seeds, MD Feb 26, 2026
The Role of Spermidine and Endothelial Regeneration
Recently I presented a Rabbit Hole (1/19/2026) related to the polyamine, spermidine, in response to a 2025 article, “Polyamines sustain epithelial regeneration in aged intestines by modulating protein homeostasis,” which appeared in Nature Cell Biology. I was fascinated by the premise of this study because it not only provides a mechanistic way of looking at […]
READ ARTICLE
SSRP Institute Feb 26, 2026
Tracking the History of Cells
In a paper published in the January 2026 issue of Science, scientists at the Harvard-MIT Broad Institute recently developed a technique called TimeVault, which turns naturally occurring cellular “vault” particles into tiny intracellular time capsules that store a lasting record of past gene expression. By engineering vault-forming proteins to capture messenger RNA (via poly(A)-binding proteins), […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Feb 23, 2026
Ep. 076 - Rethinking OCD Through a Cellular Medicine Lens
Preview Only
Dissecting Protocols – Episode 076

Rethinking OCD Through a Cellular Medicine Lens

Dr. Seeds explores OCD as a circuitry and maladaptive learning issue, discussing neurotransmitter balance, oxidative stress, and mitochondrial function while highlighting a non-SSRI approach that pairs cellular support with ERP to promote lasting change.

Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Feb 16, 2026
Ep. 075 - The Truth About Ketone Esters
Preview Only
Rabbit Holes – Episode 075

The Truth About Ketone Esters

Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Feb 9, 2026
Ep. 074 - Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Preview Only
Journal Club – Episode 074

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions

Dr. Seeds reviews a newly published peer-reviewed article, coauthored with his colleagues, examining how cellular medicine and peptides support orthopedic wound healing through regenerative signaling and cellular repair mechanisms. (Article Link)

Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Feb 2, 2026
Ep. 073 - February '26
Preview Only
VIDEO
Cellular Medicine Mondays
Jan 26, 2026
Ep. 072 - LADA Protocol
Preview Only
Dissecting Protocols – Episode 072

LADA Protocol

Dr. Seeds answers a clinician question on implementing a LADA-focused approach, clarifying peptide sequencing, biomarker monitoring, and expectations around immune modulation, metabolic support, and beta-cell preservation within a cellular medicine framework.

Preview Only — Become a member for full access

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.